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Immune response (Ir) genes were originally discovered for responses to rela-
tively simple polymers of a few amino acids (1), the simplest being poly-L-lysine,
for whichall-or-none responsiveness wasseen in differentinbred strains of guinea
pigs (2) . The same phenomenon of Ir gene control was then found to apply to
more complex antigens such as natural proteins (3-8), but in these cases, high
or low responsiveness rather than all-or-none was the rule . In earlier studies, we
found evidence to support the hypothesis that the reason for high or low
responsiveness rather than nonresponsiveness was that the responses to different
epitopes on the same protein were under different Ir gene control (9-12) . Thus,
it was unlikely to find a strain of animals that lacked the response to all epitopes
on a complex protein . Low responders merely responded to fewer epitopes .
For these reasons, recent studies on the mechanism of action of Ir genes have
largely focused on responses to individual epitopes, most recently as represented
by small synthetic peptides (8, 13-16) . Two main types of mechanisms have been
proposed and evidence has been presented to support each : holes in the T cell
repertoire (17, 18) and preferential binding of different peptides to different
MHC molecules (19-24). Probably both mechanisms can account for some of
the Ir gene phenomena, and suppressive mechanisms may account for others
(25) .
Although some controversy remains about the control of responses to individ-
ual epitopes, enough is now known that it is time to return to the question of
high vs . low responsiveness to whole proteins, which, after all, are what is
encountered in nature during response to infection . This second look at whole
proteins is also warranted by the fact that certain epitopes appear to be immu-
nodominant (6, 8, 26-31) . Therefore, we hypothesized that perhaps epitopes
are not all created equal but, rather, the response to some so predominates that
these alone will influence high or low responsiveness to the whole protein. Thus,
it would not be simply the relative number of epitopes to which an individual
could respond that would determine the magnitude of response to the protein,
but rather the choice of the epitopes seen would play a role as great as or greater
than that of the total number of epitopes . To study this question, we have
undertaken a large project to compare the fine specificityT cell repertoire ofa
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high responder and a low responder to sperm whale myoglobin (SWMb) .' For
this purpose, we have combined classic limiting dilution analysis with the pro-
duction oflong-term limiting dilution T cell linesand the testing offine specificity
with synthetic peptides and cyanogen bromide cleavage fragments . The results
indicate that high responsiveness depends primarily on the response to a major
immunodominant epitope . The response to other epitopes never reaches the
level of the response to this one and so does not compensate in strains that lack
responsiveness to the immunodominant site . Therefore, although low responders
respond to a number of epitopes, they remain low responders . In addition to the
implications for Ir gene control of the response to natural proteins, these results
support the notion that immunodominant epitopes are distinct from other
epitopes in some important way .
Materials and Methods
Mice. C57BL/10 (B10), B10.D2, B10.BR, and (B10.BR X B10.D2)F, mice were
purchased from The Jackson Laboratory (Bar Harbor, ME) . BIO.A(4R), B10.GD, and
B10.S were bred at our breeding facility from breeding pairs kindly provided by Dr . D .
H . Sachs (National Institutes of Health) and Dr . D . Shreffler (Washington University, St .
Louis, MO) .
Antigens.
￿
SWMb, cyanogen bromide cleavage fragment 1-55, and synthetic peptides
102-118 and 132-146 ofSWMb were prepared as previously described (4, 11, 32, 33).
Long-term Limiting Dilution Analysis.
￿
(B10.BR XB10.D2)F, mice were immunized with
100,ug of SWMb in CFA (1 :1) subcutaneously in the tail . 8 d later, draining lymph node
cells were collected, and T cells were enriched by passage through a nylon-wool column .
They were stimulated in 24-well plates with 1 .5,uM SWMb and rested one cycle on 3,300-
rad irradiated F, spleen cells by the method of Kimoto and Fathman (34), except that
only 106 irradiated spleen cells were used per well for the rest . The T cells were then
plated in serial dilutions of 60 wells each at 800, 200, 40, 13, and 4 cells per well in 96-
well microtiter plates with 5 X 105 irradiated spleen cells in the presence ofSWMb and
IL-2 (4 U/ml) . Since responses ofsingle precursor cells in the limiting dilution wells could
not be detected, they were repeatedly stimulated and expanded, transferred to 24-well
plates, and maintained as limiting dilution cell lines, each representing, within limits, the
repertoire of precursors plated at the original limiting dilution cell numbers. Addition of
IL-2 was stopped after a second stimulation in 24-well plates . Each line was tested for
proliferation to SWMb, fragment 1-55, and peptides 102-118 and 132-146, and for
recognition of these on presenting cells of congenic B10.D2 (Ad , Ed), B10.GD (Ad only),
B10.BR (A ° , E'), andBIO.A(4R) (A° only) strains . The results were calculated by a Poisson
analysis using a least squares fit algorithm .
TCell Proliferation Assay.
￿
The proliferative response ofT cells was assayed as described
previously (27) with some modifications . To increase the chances to detect the response
of minor clones in each cell line, up to 1 .5 X 105 cells were cultured with 2.5 X 105
irradiated spleen cells and antigens in microtiter wells . 3 d later, 1 pCi of [ 5H]thymidine
per 20 /,1 was added per well and harvested 18 h later onto glass fiber filters . The
radioactivity uptake was measured by liquid scintillation counting .
Medium.
￿
Complete medium consisting of the following components was used in all
cell cultures : 10% heat-inactivated FCS, 5 X 10-5M 2-ME, 2mM fresh L-glutamine, 100
U/ml penicillin, 100 jAg/ml streptomycin (Gibco Laboratories, Grand Island, NY), 5%
Hepes in a 1 :1 mixture of RPMI 1640, and Eagle-Hank's amino acid medium made for
5% C0 2 conditions (35) . All cultures were carried out in a humidified C0 2 incubator set
at 5% C0 2 , 37 0C .
1 Abbreviation used in this paper.
￿
SWMb, sperm whale myoglobin .1102
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FREQUENCIES OF H-4d-OR H-r-RESTRICTED
(B10.BR x B10.DQJ F1 TCELLS SPECIFIC FORSWMb FIGURE 1 . Frequencies of H-2d- or H-2°-re-
stricted (B10.BR x B10.D2)F, T cells specific for
SWMb. Long-term limiting dilution cell lines re-
stricted to H-2° or H-2', raised as described in
Materials and Methods, were tested forprolifera-
tive response to 2AM SWMb on each haplotype of
APCs. Thefraction ofpositive respondingcell lines
among 60 replicates of the original limiting dilu-
tion doseswere subtracted from 1.0 andplotted as
a function of dilution dose (800, 200, 40, and 13
perwell). Lineswere drawn by least square linear-
ization, and frequencies were calculated from the
point at which the fraction of nonresponding cul-
tureswas 0.37, accordingto Poisson statistics.
Results
SWMb-specific, Long-term Limiting Dilution Lymph Node Cell Lines.
￿
In vivo-
primed (B10.BR [low responder] x B10.D2 [high responder])F, lymph node
cells were stimulated and rested one round in vitro with F, APC to reduce
autoreactive and nonspecific T cells and acclimate the cells to tissue culture.
Serial dilution inocula (800, 200, 40, 13, and 4 cells per well) were then cultured
with parental high or low responder APCs in the presence of IL-2 and antigen.
These were repeatedly stimulated, expanded to levels at which they could be
tested for responses to different peptides, and maintained as limiting dilution
cell lines. It is possible that some precursors in any given well were lost during
the expansion stage. However, since it was impossible to detect the responses of
single cells, especially in multiple tests, we took each cell line as a statistically
reasonable (over the whole study), if individually imperfect, representation of
the precursors that went into that well.
Each cell line was initially tested for reactivity to SWMb. The results were
calculatedby Poisson analysis based on the number of cellsper well in the original
limiting dilution (Fig. 1). The frequencies of SWMb-specific T cells restricted to
H-2d or H-2k at the time of the limiting dilution were 1 :475 and 1 :1,708,
respectively . Thus, there was a 3 .6-fold difference in the number of T cells
between the high and the low responder MHC restrictions.
Comparison of Efficiency of(B10.BR x B10.D2)F, APC to Stimulate H-2
d- or H-
2''-restricted Cell Lines. Since limiting dilution was carried out after one round
of stimulation and rest in vitro to adapt the cells to culture, and since the mice
were immunized in vivo in the endogenous F, environment, the difference in
the frequencies of H-2d- or H-2k-restricted T cells could be due to a different
efficiency of expansion between H-2d- and H-2k-restricted T cells stimulated
with F, APC and antigen before the limiting dilution. To test this possibility, we
titrated the F, spleen cells for their efficiency in stimulating randomly selected
H-2d- and H-2k-restricted cell lines from the limiting dilution . If cells of one of
the restriction types show a much steeper response curve on titrating F, APC,
an uneven expansion of the T cells probably occurred between the different
restriction specificities in vivo and during one round of stimulation and rest in
vitro before the limiting dilution. Although there were cell line-to-cell line
differences, the result did not seem to show significant differences between the
two restriction types (Fig. 2). Of course, we could study only those cell lines thatb
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FIGURE 2.
￿
Titration of F, APC to stimulate H-2d- or H-2'-
restricted F, Tcell lines . Five each of randomly selected H-2'-
or H-2'-restricted cell lines were cultured in microtiter wells (2
X 10' cells per well) with 2pM SWMb and 5 X 105 , 2 X 10 5 , 8
X 10', or 3.2 X 10' of irradiated F, spleen cells per well .
[9H]Thymidinewasadded 3d later, and its uptake wasmeasured
as described in Materialsand Methods. Background levels were
as follows : 28,000-92,000cpm(0); 180-990 cpm (A) ; 190-420
cpm ([1) ; 330-560 cpm (p); 175-400 cpm (O); 2,900-12,300
cpm (0);280-570cpm (A) ; 145-410cpm (") ; 640-41,490 cpm
(") ; 26,900-103,600 cpm, (/; which were completely autoreac-
tive) .
FIGURE 3 .
￿
Frequencies of different fine specific-
itiesamongH-2'-restricted (BI 0.BR X BI0.D2)F,
T cells. The H-2'-restricted cell lines were tested
for proliferative response to 2 AM SWMb (0), 1
1AM fragment 1-55 (A), 1 1AM peptide 102-118
(O), and 1 wM peptide 132-146 (O) . For details,
see legend for Fig. I andMaterialsand Methods .
grew . Thus, of necessity, there is an inherent selection for cells that grow under
our culture conditions . With that qualification, if these are representative, we
could not explain the frequency differences in the restriction types on the basis
of greater sensitivity ofone population to stimulation on F,-presenting cells .
Fine Specifcities of SWMb-specific H-2d- or H-2k-restricted F, T Cells.
￿
SWMb-
specific B10.D2 clones and their fine specificities have been well studied (27, 28,
32, 33) . Namely, dominant clones were specific for the epitope around glutamic
acid at position 109 (Glu 109) and restricted to I-Ad; I-Ed-restricted T cells were
far less frequent, and the majority of those clones is specific for lysine at position
140 (Lys 140) . Some other clones respond to the cyanogen bromide cleavage
fragment 1-55 on I-Ad , but finer mapping of their specificity is unknown .
Considering these facts, we tested the same limiting dilution T cell lines for
the frequency of wells responding to different peptide fragments with different
MHC restrictions . Fig. 3 shows the results of the fine specificities in H-2'-
restricted cell lines . The majority of SWMb-specific H-2d-restricted T cells
responded to the synthetic peptide of residues 102-118 (which includes Glu 109
and stimulates established Glu 109-specific T cell clones) . The frequency was
1 :645 compared with a total frequency in the experiment of 1 :475 (i.e ., 74%) .
TheT cells specific for peptide 132-146 were far less frequent (1 :4,876) and1104
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(B10-BR x B10.D2)F, T cells. The H-2d-
or H-2'-restrictedT cell lines were tested
as for response toSWMb or the peptides on
<iaioo
￿
B10.GD (Adgb
) or B10.A(4R) (A'E°) spleen
cells as APCs, respectively. Also 1 gg/ml
Con A was tested to stimulate T cells on
B10.A(4R) spleen cells, which gave thou-
sands to 200,000 cpmof ['Hlthymidine in-
corporation . For details, see legend for Fig.
1 and Materialsand Methods .
FIGURE 4 .
￿
Frequencies ofdifferent fine specific-
ities amongH-2`-restricted(B10.BRX B10.D2)F,
T cells . The H-2'-restricted limiting dilution cell
lines were tested for SWMb (O), 1 gM fragment
1-55 (A), 1 pM peptide 102-118 (p), and 1 uM
peptide 132-146 (O) . For details, see legends for
Figs. 1 and 3 .
represented <10% of the SWMb-specific T cells, consistent with the magnitude
of the bulk lymph node T cell response to 132-153 vs . whole SWMb (11) . In
addition, a number of T cells responded to the fragment 1-55 (1 :1,143) .
Although even approximate boundaries of an epitope(s) within the 1-55 region
have not yet been defined, these results indicate that H-2'-restricted T cells see
at least three parts of the whole molecule of 153 amino acids, spreading out
somewhere near the NH2 terminal through 102-118 in the middle cyanogen
bromide cleavage fragment to the COOH-terminal peptide 132-146 .
In contrast, most of the H-2'-restrictedT cells responded to the fragment 1-
55 (1 :1,927 ofa total of 1 :1,708), and few, ifany, couldbe stimulated by peptide
102-118 or 132-146 (<1 :60,000 ; Fig. 4) . Furthermore, no detectable H-2'-
restrictedT cells responded to SWMb on B10.A(4R) spleen cells that bear only
I-A' and not the I-E'` molecule (Fig . 5, right) . Other accessory functions of the
B10.A(4R) spleen cells were intact, as T cells could be stimulated well with Con
A on the 4R spleen cells (data not shown) . Thus, their restriction was limited to
AMONG I-Ad- OR I-At- RESTRICTED IS10.SRx 81&02)F, T CELLS specificities among dk
Both I-Ad and I-Ed restrictions were seen in H-2d-restricted response . Almost
all of theT cell lines that responded to peptide 102-118 could be stimulated by
the same peptide on B10.GD spleen cells that have only I-Ad (Fig . 5, deft; 1:673
compared with 1:645 in Fig . 3) . The response to peptide 132-146 was not seen
on B10.GD APC, confirming that the response is restricted to I-Ed (28) . The
majority of the T cells specific for the fragment 1-55 responded on B10.GD
spleen cells (i.e ., wereAd restricted) . Although the first limiting dilution experi-
ment did not have enough data on the restriction of response to fragment 1-55KOJIMA ET AL.
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TABLE I
Summary of Clonal Frequencies
because of the short supply of the fragment, the result was confirmed in the
second limiting dilution experiment (Table I).
To confirm these results, the limiting dilution analysis was repeated on a
slightly smaller scale with a new group of F, mice. The results, summarized in
Table 1, showed that (a) the majority of H-2'-restricted T cells was 102-118
specific and I-Ad restricted; (b) the response to peptide 132-146 was not seen on
I-Ed- BIO.GD APC; (c) none of the H-2'-restricted T cells responded to peptide
102-118 or 132-146; and (d)whole SWMb and fragment 1-55 did not stimulate
H-2k T cells on I-Ek- BIO.A(4R) APC. In addition, a new peptide 59-80 that
covers one ofthe amphipathic helical regions ofSWMb (36, 37) was synthesized
(Cease K. B., S. J. Brett, M. Kojma, andJ. A. Berzofsky, manuscript in prepara-
tion). This peptide was shown to stimulate SWMb-primed lymph node T cells
from H-2k mice and was identified independently by Livingstone and Fathman
(38), so the new peptide was also tested for its ability to stimulate the second set
ofthe limiting dilution cell lines.
Strikingly, the peptide 59-80 stimulated almost all ofthe H-2k-restricted cell
lines very well. The majority of these T cells responded to both peptide 59-80
and fragment 1-55. The frequencies from Poisson analysis indicate that there
must be dual specificities or crossreaction between 59-80 and 1-55. We have
some preliminary evidence for possible crossreaction (unpublished observations),
but for purposes of the issues addressed in the current paper, the exact fine
specificities of these cells are not critical. Further work with additional peptides
will be required. In contrast to the H-2'-restricted cells, 59-80-reactive H-2d-
restricted Tcells were very rare, and only one cell line responded to it.
Theseresults indicate that low responder H-2k-restricted Tcells have a limited
repertoire to see myoglobin only in the 1-55 region or 59-80 region with I-Ek
restriction. High responder H-2'-restricted T cells have a much broader spec-
trum of fine specificities using both I-Ad and I-Ed restriction elements and, in
particular, respond to the immunodominant antigenic site around Glu 109 in
the context of I-Ad.
Response of H-2s- or H-26-restricted T Cells to the Peptides.
￿
Besides H-2d and
Exp. Restriction
SWMb 1-55
Antigen
59-80 102-118 132-146
1 H-2d 1:475 1:143 1:645 1:4,876
I-Ad 1:480 1:673 <1 :63,400
I-Ed 1:4,876
H-2k 1:1,708 1:1,927 <1 :63,400 <1 :63,400
I-Ak <1 :63,400 <1 :63,400 <1 :63,400 <1 :63,400
I-Ek 1:1,708 1:1,927 <1 :63,400 <1 :63,400
2 H-2d 1:398 1:2,390 1:10,565 1:393 1:7,015
I-Ad 1:398 1:2,390 1:10,565 1:449 <1 :14,400
I-Ed 1:7,015
H-2k 1:1,018 1:1,434 1:999 <1 :30,000 <1 :30,000
I-Ak <1 :30,000 <1 :30,000 1:1,818 <1 :30,000 <1 :30,000
I-Ek 1:1,018 1:1,434 <1 :30,000 <1 :30,0001106
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FIGURE 6 .
￿
Fine specificities ofSWMb-
specific B10.S T cell line. The SWMb-
specific B10.S T cell line was made by
the same method as the (B10.BR X
B10.D2)F, T cell lines but without lim-
iting dilution . After four rounds ofstim-
ulation cycles, the polyclonal T cell line
was tested for proliferation to SWMb,
fragment 1-55, and peptides 59-80,
102-118, and 132-146 . For details, see
Materials and Methods .
H-2k, H-2s is another high responder and H-2b is another low responder to
SWMb (4, 11, 12). To extend the information on the mechanism of high and
low responsiveness, SWMb-specific short-term B10 and B10.S T cell lines were
tested for their response to the synthetic peptides and the fragment 1-55 . The
T cell lines were stimulated and rested for more than five rounds to reduce
background response and to enrich specific T cells . The B10.S line showed a
strong response to peptide 102-118 and fragment 1-55 but did not respond to
either peptide 59-80 or 132-146 (Fig . 6) . Since H-2$ has only I-A molecules,
again the dominant response in this other high responder was toward peptide
102-118 plus the I-AS restriction element, as suggestedfrom the crossreactivities
for whale myoglobin evolutionary variants (26) .
The B10 line, in turn, showed a strong response only to fragment 1-55 and
no response to peptide 59-80 or 132-146 (Fig. 7) . A very weak response could
be detected to peptide 102-118 in the whole population, but most of the cell
line consisted of 1-55-specific T cell clones, and no 102-118-specific clones
could be isolated. The response to peptide 102-118 was not observed in fresh
lymph nodeT cells(data not shown), so repeated stimulations may have enriched
the 102-118-specific T cells to a detectable level . However, the response was
still low . It might be that (a) peptide 102-118 did not cover required amino acid
sequences and only caused weak stimulation to the H-2b-restricted T cells; (b)
SWMb was never processed to show epitope(s) of peptide 102-118 and T cells
specific to this peptide survived with bystander help; or (c) a suppression mech-
anism reduces response to peptide 102-118 . Whatever the case is, response to
peptide 102-118 was marginal in I-Ab-restrictedT cells .
Thus, the overall picture appears to be that the high responder H-2d- and H-
2$-restricted T cells could respond to the immunodominant peptide 102-118 in
the context of an I-A molecule, and the lowresponder H-2k- and H-2b-restricted
T cells lack this dominant response to peptide 102-118 plus an I-A restriction
element . Both low responders appear to have a more limited T cell repertoireKOJIMA ET AL .
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FIGURE 7 . Fine specificities of
SWMb-specific B10T cell lines and
clones . SWMb-specific B10 T cell
line was prepared by the same
method as the B10.S T cell line .
After six rounds of stimulation cycles
when T cells started to expand, they
were cloned out at a dilution of 0.3-
0.5 cellsper well, twice . Clones E8E9,
2D5B12, and 2D5E2 were tested
along with the B10 line for prolifer-
ation to SWMb, fragment 1-55, and
peptides 59-80, 102-118, and 132-
146 .
focused on the region 1-55 (or the crossreactive 59-80) and use a single
restriction element (I-Ek for H-2k, and I-A6 for H-2b) .
Discussion
A long-term limiting dilution Poisson analysis was performed to approach the
question of why a high responder is high and a low responder is low in response
to awhole complex protein antigen, in this case, SWMb . (BI0.BR [low] x B1 0.D2
[high])F, T cells, after limiting dilution, were repeatedly stimulated, expanded,
and maintained on high or low responder APCs as limiting dilution cell lines .
Their reactivities to fragment 1-55, peptide 102-118, or peptide 132-146,
along with their Ir restrictions, were scored as a function of the original limiting
dilution cell numbers, and the frequencies ofT cells of each fine specificity were
calculated according to a Poisson distribution . The results showed that (a) there
was only a fewfold difference in frequencies between H-2d (B10.D2)-restricted
and H-2k (B10.BR)-restricted F, T cells specific to SWMb ; (b) H-2d-restricted
T cells had a broader spectrum of fine specificities using both I-Ad and I-Ed
restriction elements, especially focused on an immunodominant epitope defined
by peptide 102-118 in the context of 1-Ad ; (c) most of the I-Ed-restrictedT cells
were specific for peptide 132-146, and the frequency of such cells was ^-10% of
the total H-2d-restricted SWMb-specific T cells ; (d) low responder H-2k-re-
stricted T cells had a limited repertoire for SWMb confined to 1-55 or 59-80
in association with I-Ek and lacked a response to the immunodominant site 102-
118 in the context of an I-A molecule ; (e) a comparable number of H-2d- and
H-2k-restricted T cells were stimulated with fragment 1-55 ; and (f) the other
high responder strain (H-2s), which expresses only an I-A molecule, also showed
a strong response to peptide 102-118 and to fragment 1-55, whereas in the
other low responder strain B10 (H-2b, I-E negative), T cells were mostly specific
for 1-55 and only marginally responsive to peptide 102-118 (which did not
stimulate a lymph nodeT cell response at all) . Thus, we conclude (a) that there1108
￿
LIMITING DILUTION ANALYSIS OF Ir REPERTOIRES
was a consistent difference between the number of cells responding to the
immunodominant epitope 102-118 in association with I-A and the numbers
responding to other minor epitopes; and (b) that high responsiveness correlated
with the response to this immunodominant epitope, whereas low responsiveness
correlated with a lack of response to this epitope, even though other epitopes
were seen.
The finding of only a fewfold difference in the frequencies of SWMb-specific
T cells between high and low responder MHC restriction may be due (in part)
to the first round stimulation and the rest of F, T cells on F, APC in vitro. Also,
since we could not see a primary SWMb-specific response in vitro, it was
obligatory to prime in vivo in the first place, so any difference in efficiency of F,
APC might have already produced an effect even before in vitro culture on F,
APC. To test the possibility that stimulating F, APCs would favor only one of
the parental MHC-restricted T cells to expand, an F, APC titration was carried
out. The result did not show any significant difference in the ability of F, APC
to stimulate groups of randomly chosen cell lines of both MHC restriction types,
although some variation from cell line to cell line was seen within each group.
Thus, if the lines that grew at all in vitro on parental presenting cells were
representative, we could not find evidence for any selective pressure due to
preferential sensitivity of the different restriction types for growth with F,-
presenting cells in vivo or during the first round of stimulation in vitro. In
addition, when SWMb-primed F, lymph node T cells were tested with the
adjuvant component PPD as a control, the H-2d-restricted response was barely
1 .5-fold higher than the H-2'-restricted response. This difference is much less
than that for myoglobin and is not likely to be the general case for all antigens,
because a low responder to SWMb may be a high responder to other antigens.
These results suggest that the low response of F, T cells on H-2'-presenting
cells may be due to the failure to see myoglobin plus I-A', in particular the major
site around Glu 109, in contrast to the dominant response of high responder
H-2d and H-25 strains focused on the I-A molecule and the site around residue
109 . I-A+ I-E- low responder B10 mice, which are forced to use an I-A restriction
element, also did not focus on 102-118. High response may be based on the
additional response of T cells that are specific for 102-118 plus an I-A molecule,
over and above the response to fragment 1-55 by other T cells, which were
common in both high and low responder strains. We do not have strains that are
negative to fragment 1-55 and so cannot determine whether strains that respond
to peptide 102-118 and not to fragment 1-55 would still be high responders or
not. Because the difference in the frequencies of SWMb-specific F, T cells
between high and low responder MHC restrictions was only a fewfold, it seems
to be unlikely that precursor T cell frequencies alone determine high respon-
siveness or low responsiveness, unless there is a threshold in the number of T
cells to be expanded within the few fold differences. One way to study the
importance of 102-118-specific T cells and the influence of 1-55-specific T cells
may be to make a high responder mouse tolerant to the 102-118 peptide or to
fragment 1-55. This raises quite an interesting problem of whether tolerance to
a major antigenic epitope would result in low responsiveness to a certain antigen
or not.KOJIMA ET AL.
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From these results, what can we say about the mechanism of Ir gene control
of immune responses to natural whole protein antigens as might be encountered
in nature or in vaccines? The failure of H-2'-restricted T cells to respond to the
immunodominant site around residues 102-118 in association with A' could still
be due to either of the two just-mentioned mechanisms; i.e., 102-118 could fail
to bind to A' or the T cells could be absent from the repertoire for other reasons.
What is newly emphasized by this study is that although two strains may have
comparable responses to other epitopes, such as ones in the 1-55 region, the
difference between a high responder and a low responder can depend not just
on the number of epitopes seen but on the presence or absence of a response to
a single immunodominant site. This can occur because the response to that site
stands out in magnitude greater than the response to any of the other sites to
which both strains respond. Why should the response to one site so predominate;
i.e., be immunodominant? Why does the response to other sites not make up for
the lack of a response to this one in strains that do not see it? It does not appear
to be simply due to a greater efficiency of presentation by F,-presenting cells, at
least as detectable in a titration of presenting cell numbers as in Fig. 2 . Since
whole myoglobin was used in these titrations, but the T cells were specific for
different epitopes, it does not appear to be due to a greater efficiency of
processing of the antigen to produce one peptide vs. the other. Similarly, there
is not a striking difference in peptide dose-response curves to account for the
differences seen. If simply the affinity of each peptide for its respective MHC
molecule made the difference, then one would expect that the immunodominant
site would stimulate at a lower concentration than a nonimmunodominant site.
One possibility is that the repertoire for the immunodominant site is inherently
larger. While this may relate to the repertoire development in the responding
individual, it is also possible that it depends on certain properties intrinsic to the
antigen. We know that there are multiple ways of seeing the 102-118 peptide
by different T cell clones (33), and the same observation applies to other
immunodominant sites of other antigens, such as lysozyme (29, 39, 40), OVA
(41), and cytochrome c (42). If an immunodominant site is actually a cluster of
overlapping epitopes, the repertoire that can see that region may be greatly
increased. An intrinsic structural property of such sites, such as but not limited
to amphipathicity (36, 37, 43, 44) or a-helicity (42, 43, 45, 46), may make them
inherently more likely to be seen by T cells and therefore to elicit a broader
repertoire beyond any differences in affinity for a particular MHC molecule or
any single T cell receptor. Certainly these other factors are important, but these
intrinsic features of certain sites would appear to operate on another level, on
which these other selective factors are then superimposed. An additional possi-
bility is that the immunodominant epitopes may be the ones that are less
downregulated by (or less susceptible to) suppressor or other regulatory mecha-
nisms. The T cells specific for minor epitopes may be kept from expanding to
immunodominant levels by such regulatory mechanisms. The aggregate of all
these effects, we suggest, leads to immunodominance and the quantitative differ-
ence between a high responder and a low responder.111 0
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Summary
To approach the mechanism that determines Ir gene-controlled high or low
responsiveness to whole proteins, such as sperm whale myoglobin (SWMb), we
compared the repertoires of high and low responder haplotype-restricted T cells
for different myoglobin epitopes by limiting dilution frequency analysis. Poisson
analysis was performed using long-term limiting dilution cell lines of (B I O.BR
[low] x B10.D2 [high])F l T cells maintained on high or low responder APCs.
The cell lines were tested with SWMb peptides and fragments for T cell
repertoire fine specificities and la restrictions. The frequency of SWMb-specific
F, T cells responsive on B I O.BR (H-2k) APCs was 2 .5-3 .6-fold lower than on
B 10.D2 (H-2 d) APCs. Strikingly, all of the H-2 k-restricted T cells used I-E k as a
restriction element, whereas both I-Ad- and I-Ed-restricted T cells were found
among the H-2d-restricted lines. The I-Ad-restricted T cells were dominant,
and the majority was specific for the synthetic peptide 102-118. T cells specific
for peptide 132-146, dominant in association with I-Ed, were less frequent.
However, no detectable H-2 k-restricted T cells were specific for either of these
peptides, but instead they were specific for fragment 1-55 or peptide 59-80.
Fragment 1-55 also stimulated a similar number of H-2 d-restricted T cells.
Therefore, the low response of F, T cells on H-2k-presenting cells may be due
to the failure to see myoglobin plus I-Ak, in particular the immunodominant site
around Glu 109, in contrast to the dominant response of high responder mice
(both H-2 d and H-2s) focused on the I-A molecule and the site around residue
Glu 109 . The I-E- low responder B 10 strain also failed to respond to peptide
102-118, supporting the idea that the low responder status results from a limited
repertoire lacking response to 102-118 plus I-A. In those strains that respond
to the immunodominant site 102-118, the frequency of T cells in the repertoire
specific for this site was always considerably greater than that for other sites.
Theseresults suggest that there is an important difference between immunodom-
inantepitopes and minor epitopes and that Ir gene-controlled low responsiveness
to a natural whole protein may be due primarily to the failure to respond to a
single immunodominant site, even though a number of other epitopes can be
recognized.
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